Protein Caging Tools for Protein Photoactivation: History
View Latest Version
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:
Satoshi Yamaguchi
,

In biosciences and biotechnologies, it is recently critical to promote research regarding the regulation of the dynamic functions of proteins of interest. Light-induced control of protein activity is a strong tool for a wide variety of applications because light can be spatiotemporally irradiated in high resolutions. Therefore, synthetic, semi-synthetic, and genetic engineering techniques for photoactivation of proteins have been actively developed. As a solution for overcoming barriers in conventional ones, researchers' recent approaches in which proteins were chemically modified with biotinylated caging reagents are introduced to photo-activate a variety of proteins without genetic engineering and elaborate optimization.

  • protein caging
  • optogenetics
  • genetic code extension technology
  • expressed protein ligation
  • photolytic protein aggregates

1. Introduction

Methods for photo-regulating the function and quantity of proteins are attracting attention in a wide range of fields, from fundamental research in molecular biology [1][2][3][4][5] to drug delivery systems [5][6][7][8][9]. In these methods, proteins are activated [2][3][4][5][10][11][12] or released from their carriers in response to light irradiation in and around cells [6][7][8][9][13][14]. Due to the high spatial and temporal resolution of light, the function of the protein can be selectively exerted at the desired location and at the desired time. The amount of active protein expressed can be remotely controlled by light. Therefore, researchers can obtain spatiotemporal information on the function of proteins by controlling the location and timing of light irradiation, giving insight into the dynamic roles of proteins in biological systems. Furthermore, light-induced activation and release of proteins are expected to reduce the off-target effects of protein-based drugs, and moreover potentially enable therapeutic effects to be obtained by producing only the minimum amount of therapeutic proteins selectively in the affected area.
In recent years, optogenetics based on naturally occurring light-responsive proteins has been widely reported as a method for photo-regulation of proteins [3][4][15][16][17][18]. Light-dependent interactions and structural changes of light-sensing proteins such as cryptochrome-2 [16], vivid [17] and phototropin [18], which are derived from plants and fungi, have been used to control the activity of functional proteins, including membrane receptors [16], gene-editing enzymes [17] and antibodies [18]. In these methods, a light-responsive protein that is genetically engineered is expressed as a fusion protein consisting of a functional protein of interest and a light-sensing domain such as the LOV domain of phototropin, which is the most familiar in optogenetics [18]. Since all parts of the protein can be expressed genetically, it is simple to express the desired photo-responsive proteins in living cells by the introduction of the gene using plasmid DNA or a virus vector. In the case that the protein of interest is activated by dimerization or complexation, it is relatively easy to design the photoactivatable fusion proteins. However, for many other proteins, the proteins of interest must be engineered elaborately to introduce optogenetics through reversibly partitioning them, in which the partitioned proteins are inactive before light-induced dimerization or complexation [17]. In addition, after photoactivation, the optogenetically activated proteins are kept to fuse to light-responsive domains, and such fusion with exogenous ones may reduce the activity and limit the range of applications. Recently, a photocleavable protein has been reported as a new category of optogenetics [19][20]. In the pioneering report, the protein of interest was tethered to the membrane through the photocleavable protein, and after exposure to light, the active protein without any fusion partner was released from the membrane, leading to light-induced localization and activation [19]. This approach can simply design light-induced release of wild-type protein from specific organelle by fusion with organelle-localizing proteins through the photocleavable protein, but there are also many proteins whose activity cannot be suppressed before exposure to light by control of localization alone. Thus, although optogenetics is an extremely attractive tool for intracellular protein photoactivation, it may not be suitable for some applications in terms of convenience and versatility.

2. Caged Proteins

Methods for converting proteins to photo-responsive ones by reversible chemical modification have also been used as a complementary approach in which intact proteins with no modification are produced after photoactivation [10][11][12][21][22][23]. In the field of chemical biology, inactivation of biomolecules by modification with photodegradable protective groups is called “caging”, and such protected compounds are called caged compounds [10][21]. Caging have been employed for activating biomolecules of interest at desired timing and location by exposure to light (Figure 1A). For example, a caged glutamine was reported to be introduced into a neuron, and then one of the dendrites was site-specifically exposed to light. As a result, the shape change of the light-exposed dendrites clearly indicated the molecular system in which glutamine affects the shape memory of neural spines [24]. Thus, caging has been utilized as a powerful research tool for giving new insight into molecular mechanisms in cell biology. Such a caging approach has also been applied to proteins, and caged proteins have been reported for more than a quarter of a century [22][23]. The simplest strategy for preparing caged proteins is to randomly introduce a photodegradable protecting group to the amino group on the protein surface through the reaction with an active carbonyl group (Figure 1B) [25][26][27][28]. In this method, in principle, almost all proteins can be caged without any pretreatment simply by mixing a reactive photodegradable protecting reagent (a caging reagent). After the protective group is degraded by light, the caged lysine residue returns to the original lysine one without leaving any trace, so there is no need to consider the effect of caging on the protein function after photoactivation. This is a great advantage when studying the function of a protein or using it as a drug. Actually, the polymerization activity of G-actin was photo-regulated by this caging strategy [25]. The selective binding function of antibodies were demonstrated to be remotely controlled by light exposure [27]. In a similar way, the carboxylic acid moiety on protein surfaces was reported to be randomly blocked with the diazo derivatives of photolytic protection groups [29]. This method realized photoactivation of hemoglobin. However, unlike small caged compounds, such random introduction of a small photodegradable protecting group onto the surface of a large protein often fails to fully inactivate the function of the protein (Figure 1C). In the case of enzymes, for example, this simple strategy based on random amine modification can function only on the enzymes that happen to have lysine residues at sites involved in catalytic activity or substrate binding (Figure 1B). Therefore, caging of proteins often requires the strategy of introducing the photodegradable protecting group specifically at the sites involved in their activity.
Figure 1. Schematic illustration of caging of compounds and proteins. (A) Caging of small molecular compounds. (B) Successful and (C) unsuccessful caging of proteins through random modification of lysine residues.

3. Site-Specific Protein Caging

As a method for site-specific introduction of the photodegradable protecting group, the use of the cysteine residue of the proteins has been utilized [11][30][31][32][33][34]. The selective reactivity of the thiol group realized the site-specific caging of the cysteine residue of which there are often one or a few on protein surfaces. Similar to the random amine coupling, the function of intact proteins was reported to be photo-regulated by caging with thiol-reactive protecting reagents when the cysteine residues were at the sites involved in protein functions [30][31]. By this approach, the enzymatic activities of myosin [30] and β-galactosidase [31] were demonstrated to be activated by light exposure. As another method using the thiol-based reaction, the caging of thiophosphorylated proteins was also reported [32]. In this method, the threonine residue of a protein was thiophosphorylated using 3-phosphoinositide-dependent kinase, and then modified with a thiol-reactive caging reagent. After photolysis, the caged protein converted to the thiophosphorylated protein which exerted almost the same activity as the phosphorylated one. This kinase-coupled approach may be versatile for caging a variety of phosphorylated proteins. To apply such thiol-based site-specific caging approaches to any other proteins, the use of cysteine-substituted mutants has been widely utilized (Figure 2A) [11][33][34]. In this approach, the function-related site is replaced with cysteine, and a caging reagent that selectively reacts with the thiol group is applied. Based on this approach, the actin polymerization activity of cofilin, which was unknown so far, was exerted by light exposure in living cells, giving new insights into the role of cofilin [11]. Furthermore, light-induced depolymerization of actin was also achieved by caged cofilin on the glass substrate [33], and the pore-formation on cellular membranes was photo-induced by caged α-hemolysin [34]. Although this approach is simple to introduce a protecting group at the desired active site, the proteins produced after photolysis are only the cysteine-substituted mutant protein on which the mutation is introduced at a critical site involved in function (Figure 2A). Therefore, there is a high risk that the light-induced activity of the mutant protein will be inferior to that of the native one. Thus, the caging strategy based on post-translational chemical modification often requires the site-specific replacement with reactive amino acids for selective caging, and therefore, almost exclusively applied to mutant proteins.
Figure 2. Schematic illustration of site-specific caging of proteins. (A) Caging based on cysteine mutagenesis. (B) Caging based on unnatural amino acid introduction using genetic code extension technologies. (C) Caging based on protein semi-synthesis using expressed protein ligation (EPL). (D) Caging based on ligand-directed chemistry.
As a method for site-specific protein caging, another genetic approach using unnatural caged amino acids has been widely employed [5][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53]. Using the genetic code extension technology such as notably amber mutation and four-base codon mutation [43], in which an unnatural amino acid is coded to a specific codon, the desired position of the protein of interest can be replaced with a caged amino acid (Figure 2B). Until now, caged aspartic acid [35][39], caged serine [36][51], caged glycine [37][43], caged tyrosine [5][38][40][48][50], caged cysteine [42][47], caged lysine [44][49][52][53], caged phosphoserine [46] and caged phosphotyrosine [46] have been utilized for photo-activation of various proteins including enzymes [35][39][42][43][44][45], intein proteins [36][47], ion channels [37][38][40], receptors [46], phosphorylation cascade proteins [50][51], and so on [5][48][49][52][53]. The site-specific incorporation of unnatural caged amino acid into proteins was first achieved in E. coli [35][36][42][43][44] and a cell-free protein expression system [46], and subsequently their photoactivation was examined in vitro. Furthermore, the recombinant caged proteins were transduced into mammalian cells with a transfection reagent to utilize their photoactivatable functions for clarifying the spatial and temporal molecular mechanism of the living system [5][48]. Next, to photo-regulate ion channels on the plasma membrane of living cells, in situ expression of site-specifically caged proteins was performed in Xenopus oocytes by injecting the caged amino acids-combined tRNA through microinjection [37][38][40]. Recently, the genetic code extension technology has become applicable to eukaryotic cells by using the genetic expression system for the orthogonal pair of pyrrolysyl-tRNA synthetase and the corresponding tRNA, enabling the genetic incorporation of caged amino acids into proteins in yeast cells [42][51] and mammalian cells [5][49][50][51][52][53]. By using such a genetic encoding system, a pioneer group, Chin et al. demonstrated light-induced intracellular localization change of caged nuclear localization proteins in human cells [49] and achieved photoactivation of receptor-mediated signal transduction by caging a phosphorylation protein, STAT1 [50]. Furthermore, to understand the role of cancer-specific mutation, they reported to photo-activate the synthesis of the oncometabolite (R)-2-hydroxyglutarate through caging an isocitrate dehydrogenase mutant in normal cells and exposing those engineered cells to light [52]. Such genetic caging with unnatural amino acid introduction was also reported to achieve light-induced gene editing through caging of Cas9 [53], photo-activation of immune response through caging of MEK1 [5], and screening of caspase substrate proteins through caging of caspase-3 [5] in human cells. Thus, in this approach, a variety of wild-type proteins could be site-specifically caged by utilizing various caged amino acids. Moreover, this approach is advantageous in introducing a photodegradable protection into the active site inside the closed structure of proteins because the caged amino acid can be incorporated on translation before protein folding. However, it requires advanced and specialized gene engineering techniques, and therefore is not easily available.
Other strategies in protein caging have also been reported. In semisynthetic approaches, a small part of the protein was chemically synthesized by incorporating caged amino acid through peptide synthesis, and then linked with a major part of the protein to produce a site-specifically caged protein [54][55][56]. First, as a pioneering approach, site-specific caged ribonuclease S (RNase S) was prepared by mixing a synthesized caged S-peptide and S-protein [54]. RNase S is consisting of two peptide fragments, S-peptide (1-20 residues) and S-protein (21-124 residues), and these fragments bind in a self-assembly manner to exert the enzymatic activity. In this report, by optimizing the replacement site of caged amino acids in S-peptide, the caged RNase S was activated by light in an off-on manner [54]. This approach was greatly developed by the expressed protein ligation (EPL) method (Figure 2C) [55][56]. In EPL-based caging, the fusion protein of a C-terminally-truncated target protein with a self-processing intein domain is overexpressed in E. coli, and through the intein-mediated processing reaction [57], the C-terminal is converted to a reactive thioester moiety. In parallel, the C-terminal domain peptide including a cysteine residue at the N-terminal end and caged amino acids at the desired positions is chemically synthesized. Then, the caged C-terminal peptide is linked to the C-terminal end of the truncated protein through native chemical ligation [58]. A signal transduction protein with multiple caged phosphorylated serine residues was reported to be prepared by this approach [55][56]. Based on the high degree of certainty and freedom of peptide synthesis, the semisynthetic approaches allow for the precise introduction of multiple photodegradable protecting groups and the expansion of the range of amino acids that can be protected. However, the caging position is limited to the terminal sequence of proteins, leading to limitation of applicable proteins. Recently, a total chemical synthesis-based approach was also reported to overcome this limitation of the semisynthetic protein caging [59], but it requires chemical reactions that are too specialized for anyone to immediately utilize. In ligand-directed caging approaches, a ligand molecule that selectively binds to the active site of a protein assists site-specific modification with the caging group [60][61]. In a pioneering study of this approach, the substrate peptide with a thiol-reactive moiety through a photocleavable linker was utilized for active-site specific caging [60]. This synthesized peptide was recognized with enzyme and reacted with the cysteine residue selectively at the active site. Based on this approach, a protein kinase was caged in vitro and introduced into living cells by microinjection, leading to light-induced activation of phosphorylation for cellular morphological change [60]. Similarly, a small substrate analogue with photodegradable ability was reported to specifically incorporated into a serine residue at the active site of enzyme, and the protected activity of enzyme was regenerated by light [61]. Hamachi et al. have presented a number of sophisticated reports in ligand-directed chemistry for in situ protein labeling [62][63][64]. For site-specific caging, a photocleavable linker was inserted between the ligand for proteins of interest and a special reactive group, and after mixing with proteins, this caging reagent could be selectively attached to amino acid residue surrounding the active site through a ligand-directed proximity effect on the reaction (Figure 2D) [65]. By employing this method, an enzyme and a receptor protein were efficiently caged with the reagents including specific ligand, respectively, and demonstrated to be uncaged by light exposure. Thus, ligand-directed approaches can achieve site-specific caging of intact proteins of interest simply by mixing with the specific caging reagents. However, the application is limited to enzymes and binding proteins. Moreover, ligands with an appropriate dissociation constant, which must meet both the requirements for the selective binding in the caging step and the rapid releasing in the photoactivation step, are needed. Such demands of this approach may be issues in terms of versatility.

This entry is adapted from the peer-reviewed paper 10.3390/app12083750

References

  1. Gautier, A.; Gauron, C.; Volovitch, M.; Bensimon, D.; Jullien, L.; Vriz, S. How to control proteins with light in living systems. Nat. Chem. Biol. 2014, 10, 533–541.
  2. Wu, Y.I.; Frey, D.; Lungu, O.I.; Jaehrig, A.; Schlichting, I.; Kuhlman, B.; Hahn, K.M. A genetically encoded photoactivatable Rac controls the motility of living cells. Nature 2009, 461, 104–108.
  3. Inagaki, H.K.; Jung, Y.; Hoopfer, E.D.; Wong, A.M.; Mishra, N.; Lin, J.Y.; Tsien, R.Y.; Anderson, D.J. Optogenetic control of Drosophila using a red-shifted channel rhodopsin reveals experience-dependent influences on courtship. Nat. Methods 2014, 11, 325–332.
  4. Morri, M.; Sanchez-Romero, I.; Tichy, A.M.; Kainrath, S.; Gerrard, E.J.; Hirschfeld, P.P.; Schwarz, J.; Janovjak, H. Optical functionalization of human Class A orphanG-protein-coupled receptors. Nat. Commun. 2018, 9, 1950.
  5. Wang, J.; Liu, Y.; Liu, Y.; Zheng, S.; Wang, X.; Zhao, J.; Yang, F.; Zhang, G.; Wang, C.; Chen, P.R. Time-resolved protein activation by proximal decaging in living systems. Nature 2019, 569, 509–513.
  6. Tomatsu, I.; Peng, K.; Kros, A. Photoresponsive hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 2011, 63, 1257–1266.
  7. Høgset, A.; Prasmickaite, L.; Selbo, P.K.; Hellum, M.; Engesæter, B.Ø.; Bonsted, A.; Berg, K. Photochemical internalisation in drug and gene delivery. Adv. Drug Deliv. Rev. 2004, 56, 95–115.
  8. Gu, Z.; Biswas, A.; Zhao, M.; Tang, Y. Tailoring nanocarriers for intracellular protein delivery. Chem. Soc. Rev. 2011, 40, 3638–3655.
  9. Sasaki, Y.; Akiyoshi, K. Nanogel engineering for new nanobiomaterials: From chaperoning engineering to biomedical applications. Chem. Rec. 2010, 10, 366–376.
  10. Brieke, C.; Rohrbach, F.; Gottschalk, A.; Mayer, G.; Heckel, A. Light-controlled tools. Angew. Chem. Int. Ed. 2012, 51, 8446–8476.
  11. Ghosh, M.; Song, X.; Mouneimne, G.; Sidani, M.; Lawrence, D.S.; Condeelis, J.S. Cofilin promotes actin polymerization and defines the direction of cell motility. Science 2004, 304, 743–746.
  12. Deiters, A.; Groff, D.; Ryu, Y.; Xie, J.; Schultz, P.G. A genetically encoded photocaged tyrosine. Angew. Chem. Int. Ed. 2006, 45, 2728–2731.
  13. Selbo, P.K.; Sandvig, K.; Kirveliene, V.; Berg, K. Release of gelonin from endosomes and lysosomes to cytosol by photochemical internalization. Biochim. Biophys. Acta 2000, 1475, 307–313.
  14. Peng, K.; Tomatsu, I.; Kros, A. Light controlled protein release from a supramolecular hydrogel. Chem. Commun. 2010, 46, 4094–4096.
  15. Levskaya, A.; Weiner, O.D.; Lim, W.A.; Voigt, C.A. Spatiotemporal control of cell signalling using a light-switchable protein interaction. Nature 2009, 461, 997–1001.
  16. Kim, N.; Kim, J.M.; Lee, M.; Kim, C.Y.; Chang, K.Y.; Heo, W.D. Spatiotemporal control of fibroblast growth factor receptor signals by blue light. Chem. Biol. 2014, 21, 903–912.
  17. Nihongaki, Y.; Kawano, F.; Nakajima, T.; Sato, M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol. 2015, 33, 755–760.
  18. Gil, A.A.; Carrasco-López, C.; Zhu, L.; Zhao, E.M.; Ravindran, P.T.; Wilson, M.Z.; Goglia, A.G.; Avalos, J.L.; Toettcher, J.E. Optogenetic control of protein binding using light-switchable nanobodies. Nat. Commun. 2020, 11, 4044.
  19. Zhang, W.; Lohman, A.W.; Zhuravlova, Y.; Lu, X.; Wiens, M.D.; Hoi, H.; Yaganoglu, S.; Mohr, M.A.; Kitova, E.N.; Klassen, J.S.; et al. Optogenetic control with a photocleavable protein, Phocl. Nat. Methods 2017, 14, 391–394.
  20. Lu, X.; Wen, Y.; Zhang, S.; Zhang, W.; Chen, Y.; Shen, Y.; Lemieux, M.J.; Campbell, R.E. Photocleavable proteins that undergo fast and efficient dissociation. Chem. Sci. 2021, 12, 9658–9672.
  21. Ellis-Davies, G.C.R. Caged compounds: Photorelease technology for control of cellular chemistry and physiology. Nat. Methods 2007, 4, 619–6289.
  22. Curley, K.; Lawrence, D.S. Light-activated proteins. Curr. Opin. Chem. Biol. 1999, 3, 84–88.
  23. Lawrence, D.S. The preparation and in vivo applications of caged peptides and proteins. Curr. Opin. Chem. Biol. 2005, 9, 570–575.
  24. Matsuzaki, M.; Ellis-Davies, G.C.; Nemoto, T.; Miyashita, Y.; Iino, M.; Kasai, H. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat. Neurosci. 2001, 4, 1086–1092.
  25. Marriott, G. Caged protein conjugates and light-directed generation of protein activity: Preparation, photoactivation, and spectroscopic characterization of caged G-actin conjugates. Biochemistry 1994, 33, 9092–9097.
  26. Thompson, S.; Spoors, J.A.; Fawcett, M.-C.; Self, C.H. Photocleavable nitrobenzyl–protein conjugates. Biochem. Biophys. Res. Commun. 1994, 201, 1213–1219.
  27. Self, C.H.; Thompson, S. Light activatable antibodies: Models for remotely activatable proteins. Nat. Med. 1996, 2, 817–820.
  28. Ottl, J.; Gabriel, D.; Marriott, G. Preparation and photoactivation of caged fluorophores and caged proteins using a new class of heterobifunctional, photocleavable cross-linking reagents. Bioconj. Chem. 1998, 9, 143–151.
  29. Bédouet, L.; Adenier, H.; Pulvin, S.; Bedel-Cloutour, C.; Thomas, D. Recovery of the oxidative activity of caged bovine haemoglobin after UV photolysis. Biochem. Biophys. Res. Commun. 2004, 320, 939–944.
  30. Marriot, G.; Heidecker, M. Light-directed generation of the actin activated ATPase activity of caged heavy meromysin. Biochemistry 1996, 35, 3170–3174.
  31. Golan, R.; Zehavi, U.; Naim, M.; Patchornik, A.; Smirnoff, P.; Inhibition of, E. coli β-galactosidase by 2-nitro-1-(4,5-dimethoxy-2-nitrophenyl)ethyl, a photo-reversible thiol label. Biochim Biophys Acta 1996, 1293, 238–242.
  32. Zou, K.; Cheley, S.; Givens, R.S.; Bayley, H. Catalytic subunit of protein kinase A caged at the activating phosphothreonine. J. Am. Chem. Soc. 2002, 124, 8220–8229.
  33. Ghosh, M.; Ichetovkin, I.; Song, X.; Condeelis, J.S.; Lawrence, D.S. A new strategy for caging proteins regulated by kinases. J. Am. Chem. Soc. 2002, 124, 2440–2441.
  34. Chang, C.Y.; Niblack, B.; Walker, B.; Bayley, H. A photogenerated pore-forming protein. Chem. Biol. 1995, 2, 391–400.
  35. Mendel, D.; Eilman, J.A.; Schultz, P.G. Construction of a light-activated protein by unnatural amino acid mutagenesis. J. Am. Chem. Soc. 1991, 113, 2758–2760.
  36. Cook, S.N.; Jack, W.E.; Xiong, X.; Danley, L.E.; Ellman, J.A.; Schultz, P.G.; Noren, C.J. Photochemically lnitiated Protein Splicing. Angew. Chem. Int. Ed. 1995, 34, 1629–1630.
  37. England, P.M.; Lester, H.A.; Davidson, N.; Dougherty, D.A. Site-specific, photochemical proteolysis applied to ion channels in vivo. Proc. Natl. Acad. Soc. USA 1997, 94, 11025–11030.
  38. Miller, J.C.; Silverman, S.K.; England, P.M.; Dougherty, D.A.; Lester, H.A. Flash decaging of tyrosine sidechains in an ion channel. Neuron 1998, 20, 619–624.
  39. Short, G.F.; Lodder, M.; Laikhter, A.L.; Arslan, T.; Hecht, S.M. Caged HIV-1 protease: Dimerization is independent of the ionization state of the active site aspartates. J. Am. Chem. Soc. 1999, 121, 478–479.
  40. Tong, Y.; Brandt, G.S.; Li, M.; Shapovalov, G.; Slimko, E.; Karschin, A.; Dougherty, D.A.; Lester, H.A. Tyrosine decaging leads to substantial membrane trafficking during modulation of an inward rectifier potassium channel. J. Gen. Physiol. 2001, 117, 103–118.
  41. Petersson, E.J.; Brandt, G.S.; Zacharias, N.M.; Dougherty, D.A.; Lester, H.A. Caging proteins through unnatural amino acid mutagenesis. Methods Enzymol. 2003, 360, 258–273.
  42. Wu, N.; Deiters, A.; Cropp, T.A.; King, D.; Schultz, P.G. A genetically encoded photocaged amino acid. J. Am. Chem. Soc. 2004, 126, 14306–14307.
  43. Endo, M.; Nakayama, K.; Kaida, Y.; Majima, T. Design and synthesis of photochemically controllable caspase-3. Angew. Chem. Int. Ed. 2004, 116, 5761–5763.
  44. Endo, M.; Nakayama, K.; Majima, T. Design and synthesis of photochemically controllable restriction endonuclease BamHI by manipulating the salt-bridge network in the dimer interface. J. Org. Chem. 2004, 69, 4292–4298.
  45. Cornish, V.W.; Mendel, D.; Schultz, P.G. Probing protein structure and function with an expanded genetic code. Angew Chem Int Ed 1995, 34, 621–633.
  46. Rothman, D.M.; Petersson, E.J.; Vázquez, M.E.; Brandt, G.S.; Dougherty, D.A.; Imperiali, B. Caged phosphoproteins. J. Am. Chem. Soc. 2005, 127, 846–847.
  47. Ren, W.; Ji, A.; Ai, H. Caging proteins through unnatural amino acid mutagenesis. J. Am. Chem. Soc. 2015, 137, 2155–2158.
  48. Edwards, W.F.; Young, D.D.; Deiters, A. Light-activated cre recombinase as a tool for the spatial and temporal control of gene function in mammalian cells. ACS. Chem. Biol. 2009, 4, 441–445.
  49. Gautier, A.; Nguyen, D.P.; Lusic, H.; An, W.; Deiters, A.; Chin, J.W. Genetically encoded photocontrol of protein localization in mammalian cells. J. Am. Chem. Soc. 2010, 132, 4086–4088.
  50. Arbely, E.; Torres-Kolbus, J.; Deiters, A.; Chin, J.W. Photocontrol of tyrosine phosphorylation in mammalian cells via genetic encoding of photocaged tyrosine. J. Am. Chem. Soc. 2012, 134, 11912–11915.
  51. Lemke, E.A.; Summerer, D.; Geierstanger, B.H.; Brittain, S.M.; Schultz, P.G. Control of protein phosphorylation with a genetically encoded photocaged amino acid. Nat. Chem. Biol. 2007, 3, 769–772.
  52. Walker, O.S.; Elsässer, S.J.; Mahesh, M.; Bachman, M.; Balasubramanian, S.; Chin, J.W. Photoactivation of mutant isocitrate dehydrogenase 2 reveals rapid cancer-associated metabolic and epigenetic changes. J. Am. Chem. Soc. 2016, 138, 718–721.
  53. Hemphill, J.; Borchardt, E.K.; Brown, K.; Asokan, A.; Deiters, A. Optical Control of CRISPR/Cas9 Gene Editing. J. Am. Chem. Soc. 2015, 137, 5642–5645.
  54. Hiraoka, T.; Hamachi, I. Caged RNase: Photoactivation of the enzyme from perfect off-state by site-specific incorporation of 2-nitrobenzyl moiety. Bioorg. Med. Chem. Lett. 2003, 13, 13–15.
  55. Pellois, J.P.; Hahn, M.E.; Muir, T.W. Simultaneous triggering of protein activity and fluorescence. J. Am. Chem. Soc. 2004, 126, 7170–7171.
  56. Hahn, M.E.; Muir, T.W. Photocontrol of Smad2, a multiphosphorylated cell-signaling protein, through caging of activating phosphoserines. Angew. Chem. Int. Ed. 2004, 43, 5800–5803.
  57. Cotton, G.J.; Muir, T.W. Peptide ligation and its application to protein engineering. Chem. Biol. 1999, 6, R247–R256.
  58. Dawson, P.E.; Muir, T.W.; Clark-Lewis, I.; Kent, S.B. Synthesis of proteins by native chemical ligation. Science 1999, 266, 776–778.
  59. Tang, S.; Wan, Z.; Gao, Y.; Zheng, J.S.; Wang, J.; Si, Y.Y.; Chen, X.; Qi, H.; Liu, L.; Liu, W. Total chemical synthesis of photoactivatable proteins for light-controlled manipulation of antigen–antibody interactions. Chem. Sci. 2016, 7, 1891–1895.
  60. Curley, K.; Lawrence, D.S. Photoactivation of a signal transduction pathway in living cells. J. Am. Chem. Soc. 1998, 120, 8573–8574.
  61. Loudwig, S.; Nicolet, Y.; Masson, P.; Fontecilla-Camps, J.C.; Bon, S.; Nachon, F.; Goeldner, M. Photoreversible inhibition of cholinesterases: Catalytic serine-labeled caged butyrylcholinesterase. ChemBioChem 2003, 4, 762–767.
  62. Tsukiji, S.; Miyagawa, M.; Takaoka, Y.; Tamura, T.; Hamachi, I. Ligand-directed tosyl chemistry for protein labeling in vivo. Nat. Commun. 2008, 5, 341–343.
  63. Fujishima, S.; Yasui, R.; Miki, T.; Ojida, A.; Hamachi, I. Ligand-directed acyl imidazole chemistry for labeling of membrane-bound proteins on live cells. J. Am. Chem. Soc. 2012, 134, 3961–3964.
  64. Tamura, T.; Ueda, T.; Goto, T.; Tsukidate, T.; Shapira, Y.; Nishikawa, Y.; Fujisawa, A.; Hamachi, I. Rapid labelling and covalent inhibition of intracellular native proteins using ligand-directed N-acyl-N-alkyl sulfonamide. Nat. Commun. 2018, 14, 1870.
  65. Matsuo, K.; Kioi, Y.; Yasui, R.; Takaoka, Y.; Miki, T.; Fujishima, S.; Hamachi, I. One-step construction of caged carbonic anhydrase I using a ligand-directed acyl imidazole-based protein labeling method. Chem. Sci. 2013, 4, 2573–2580.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
This entry is offline, you can click here to edit this entry!
ScholarVision Creations
Feedback